JQ-1 displays antitumor effects in testicular germ cell tumors, leukemia, and prostate cancer by inhibiting BRD4, and BRD4 is a mediator of transcriptional elongation in the M/G1 cell cycle transition [32]. The gene discussed is BRD4; the disease is prostate carcinoma.